tisagenlecleucel (Kymriah)

tisagenlecleucel · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for tisagenlecleucel (Kymriah), covering 2025-06-26 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Tisagenlecleucel In Primary CNS Lymphoma [Phase 1]